A potential World Trade Organization <-bsp-bb-link state="{"bbDocId":"QSOVD8DWX2Q0","_id":"00000179-4701-d779-a37b-cfb7b2220000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">waiver-bsp-bb-link> of patent and trade secret protections for Covid-19 vaccines would leave pharmaceutical companies with limited legal avenues to recover costs.
The U.S. on Wednesday expressed support for a temporary waiver, sending shares in several vaccine makers <-bsp-bb-link state="{"bbDocId":"QSOTKCDWLU6X","_id":"00000179-4701-d779-a37b-cfb7b2230000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">down-bsp-bb-link>the next day. The issue now faces <-bsp-bb-link state="{"bbDocId":"QSOQXGDWRGGA","_id":"00000179-4701-d779-a37b-cfb7b2230001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">thorny-bsp-bb-link> negotiations at the WTO, where several members, including <-bsp-bb-link state="{"bbDocId":"QSP08LDWX2Q4","_id":"00000179-4701-d779-a37b-cfb7b2230002","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Germany-bsp-bb-link>, have opposed efforts to skirt intellectual property rights. They say it would only complicate production and make companies less likely to respond in the future.
The proposed waiver is intended to ramp up the production and export of vaccines ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.